NewGenIvf Group Limited (NIVFW)

USD 0.01

(-7.75%)

Revenue Summary of NewGenIvf Group Limited

  • NewGenIvf Group Limited's latest annual revenue in 2023 was 5.13 Million USD , down -13.59% from previous year.
  • NewGenIvf Group Limited's latest quarterly revenue in 2023 FY was 5.13 Million USD , down -13.59% from previous quarter.
  • NewGenIvf Group Limited reported a annual revenue of 5.94 Million USD in annual revenue 2022, up 44.34% from previous year.
  • NewGenIvf Group Limited reported a annual revenue of 4.11 Million USD in annual revenue 2021, down 0.0% from previous year.
  • NewGenIvf Group Limited reported a quarterly revenue of 5.94 Million USD for 2022 FY, up 44.34% from previous quarter.
  • NewGenIvf Group Limited reported a quarterly revenue of 4.11 Million USD for 2021 FY, down 0.0% from previous quarter.

Annual Revenue Chart of NewGenIvf Group Limited (2023 - 2021)

Historical Annual Revenue of NewGenIvf Group Limited (2023 - 2021)

Year Revenue Revenue Growth
2023 5.13 Million USD -13.59%
2022 5.94 Million USD 44.34%
2021 4.11 Million USD 0.0%

Peer Revenue Comparison of NewGenIvf Group Limited

Name Revenue Revenue Difference
Acadia Healthcare Company, Inc. 2.92 Billion USD 99.825%
Addus HomeCare Corporation 1.05 Billion USD 99.515%
AirSculpt Technologies, Inc. 195.91 Million USD 97.378%
Amedisys, Inc. 2.23 Billion USD 99.77%
American Oncology Network, Inc. 1.27 Billion USD 99.598%
Astrana Health, Inc. 1.38 Billion USD 99.63%
Aveanna Healthcare Holdings Inc. 1.89 Billion USD 99.729%
IMAC Holdings, Inc. 5.19 Million USD 1.171%
biote Corp. 185.36 Million USD 97.229%
Cryo-Cell International, Inc. 31.34 Million USD 83.613%
Cross Country Healthcare, Inc. 2.01 Billion USD 99.746%
COMPASS Pathways plc - USD -Infinity%
DocGo Inc. 624.28 Million USD 99.177%
The Ensign Group, Inc. 3.72 Billion USD 99.862%
Healthcare Services Group, Inc. 1.67 Billion USD 99.693%
InnovAge Holding Corp. 763.85 Million USD 99.328%
Assure Holdings Corp. 255 Thousand USD -1914.178%
The Joint Corp. 117.69 Million USD 95.636%
LifeStance Health Group, Inc. 1.05 Billion USD 99.513%
Mobile-health Network Solutions Class A Ordinary Shares 10.35 Million USD 50.416%
ModivCare Inc. 2.75 Billion USD 99.813%
Novo Integrated Sciences, Inc. 12.57 Million USD 59.146%
Option Care Health, Inc. 4.3 Billion USD 99.881%
P3 Health Partners Inc. 1.26 Billion USD 99.594%
P3 Health Partners Inc. 1.26 Billion USD 99.594%
The Pennant Group, Inc. 544.89 Million USD 99.057%
Surgery Partners, Inc. 2.74 Billion USD 99.813%
Syra Health Corp. Class A Common Stock 5.51 Million USD 6.872%
Talkspace, Inc. 150.04 Million USD 96.577%
Talkspace, Inc. 150.04 Million USD 96.577%
The Oncology Institute, Inc. 324.23 Million USD 98.416%
The Oncology Institute, Inc. 324.23 Million USD 98.416%